TPST CIK: 1544227

Tempest Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.0
FY22:
−34.6
FY23:
−29.2
FY24:
−42.0
FY25:
−26.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.6
FY22:
−33.5
FY23:
−27.7
FY24:
−40.1
FY25:
−25.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.3
FY22:
−35.7
FY23:
−29.5
FY24:
−41.8
FY25:
−26.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.3
FY22:
−35.7
FY23:
−29.5
FY24:
−41.8
FY25:
−26.3

All amounts in millions USD Data sources:SEC EDGARTwelve Data